honokiol has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Ding, H; He, W; Jiang, L; Luo, J; Wen, P; Yang, J; Zen, K; Zhang, Y; Zhou, Y | 1 |
| Deng, R; Lao, Y; Li, S; Liu, X; Lu, J; Wang, Y; Wei, X; Weng, J; Yang, S | 1 |
2 other study(ies) available for honokiol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis.
Topics: Acetylation; Animals; Biphenyl Compounds; Down-Regulation; Epithelial Cells; Fibrosis; Gene Ontology; Humans; Kidney Tubules; Lignans; Male; Mice, Inbred C57BL; Mitochondrial Proteins; Peptide Fragments; Pyruvate Dehydrogenase Complex; Renal Insufficiency, Chronic; RNA, Messenger; Sirtuin 3; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction | 2021 |
Effects of honokiol protects against chronic kidney disease via BNIP3/NIX and FUNDC1-mediated mitophagy and AMPK pathways.
Topics: AMP-Activated Protein Kinases; Animals; Membrane Proteins; Mitochondria; Mitochondrial Proteins; Mitophagy; Rats; Renal Insufficiency, Chronic | 2023 |